Showing results (1151-1160 of 1,547) with videos related to

Sort By:
Pageof 155
Communications Medicine|May 21, 2024
Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumorsJian Jenny Chen, Melanie Y Vincent, Dale Shepard, et al.
NPJ Precision Oncology|December 5, 2017
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survivalOvidiu C Andronesi, Morteza Esmaeili, Ronald J H Borra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2021
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent GlioblastomaAndrew B Lassman, Patrick Y Wen, Martin J van den Bent, et al.
Neuro-Oncology|July 6, 2019
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patientsCraig Horbinski, Keith L Ligon, Priscilla Brastianos, et al.
Nature Medicine|February 24, 2023
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trialIngo K Mellinghoff, Min Lu, Patrick Y Wen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2023
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic CharacterizationFatemeh Derakhshan, Arnaud Da Cruz Paula, Pier Selenica, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
Molecular Oncology|October 6, 2020
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomasLea A Moukarzel, Lorenzo Ferrando, Arnaud Da Cruz Paula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or LeptomeningesLaura Q M Chow, Fabrice Barlesi, Erin M Bertino, et al.
The Lancet. Oncology|April 9, 2011
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomasM J van den Bent, J S Wefel, D Schiff, et al.
Pageof 155